Biolidics' Covid-19 rapid test kit allowed to be sold in EU
Add BT as a preferred source
Vivienne Tay
Singapore
SINGAPORE-BASED cancer diagnos-tics company Biolidics on Monday said its rapid test kit for Covid-19 is allowed for sale in the European Union (EU).
This was after the test kit obtained confirmation for CE marking, a notification process to the relevant authority which allows the company to market and sell the kit in the EU. Having the CE marking confirms the test kit complies with the relevant EU product safety directives.
TRENDING NOW
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
Focus turns to Strait of Hormuz after US and Iran presidents sign ceasefire agreement
Onitsuka Tiger pivots from Asics stripes to tap luxury market
Fall in COE prices across board suggests car, commercial vehicle premiums hitting resistance level
